The recognition follows Focus's June 3, 2026 announcement that it secured C$1,378,700 in non-repayable federal funding to ...
As a leading provider of AI real-time data infrastructure and analytics services in China, Xunce Technology made breakthrough progress in the first half of the year across business models, product ...
KUALA LUMPUR, Aug 21, 2026 - (ACN Newswire) - International Sustainability Week (ISW) 2026 is putting its own carbon footprint on the record — setting an example for how sustainability events can ...
Overall, the interim results for 2026 validate the effectiveness of Chery Automobile’s dual-engine growth model: “globalization coupled with accelerated NEV volume growth”, while simultaneously ...
- Sales of HuaTangNing reached 3.055 million packs in the first half of 2026, representing a 73% year-on-year increase; revenue hit RMB378.9 million, up 74% year-on-year. The in-house ...
With the imminent inauguration of the new Huanggang Port, cross-border transport demand between Shenzhen and Hong Kong is set to rise further. To drive the digital transformation of Hong Kong’s green ...
TOKYO, Aug 20, 2026 - (JCN Newswire) - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head Office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) announced an investment in Clean Planet Inc. (Head Office: ...
Recently, Guoquan Food (02517) announced its interim results for the six months ended 30 June 2026. The Group recorded revenue of RMB3,947 million, representing an increase of 21.8% year-on-year.
HONG KONG, August 20, 2026 - (ACN Newswire) - Emperor Watch & Jewellery Limited (“Group” or “Emperor W&J”) (Stock code: 887), a leading retailer of European-made watches and jewellery products, ...
As a locally rooted city commercial bank, Bank of Chongqing has played an active role in supporting the Chengdu-Chongqing Economic Circle and the New International Land-Sea Trade Corridor. Growth ...
Fujitsu launches highly secure supply chain information sharing service, leveraging U.S. Exostar's capabilities and maintaining localized data management and operations in Japan Supporting business ...
- HiCM-188 is the first allogeneic human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) therapy studied in a randomized controlled trial for the treatment of advanced ischemic heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results